As diabetes is a major risk factor for CKD [67], specialized expert groups such as the Kidney Disease: Improving Global Outcomes (KDIGO) team, with the endorsement of both ADA and EASD, recommend that glycemic management for T2D patients with CKD should involve a combination of metformin and a SGLT-2 inhibitor as first-line therapy, with other drugs such as SUs considered only when additional therapies are needed for optimum glycemic control [68]
Then use once per week as maintenance
Results of oxidative stress and activity of glutathione-dependent enzymes Oxidative stress in rat hippocampal tissue was measured by assessing glutathione-dependent enzymes (MDA, SOD, GSH, TAC, GR, GPx, and catalase) after fever and during adolescence post-behavioral tests
doi: 10.1007/s13577-021-00535-x 65 KonecnyGEHendricksonAEWDavidsonTMWinterhoffBJMaSMahnerSet al
Its ability to enhance tissue regeneration, reduce inflammation, and support overall wellness makes it one of the most exciting peptides in modern research